Cancer screening, is it overdone?

Prostate cancer tests, so cheap and easy to administer, may do more harm than good. Now doctors are reconsidering other cancer screening tests, and whether they too are not as useful as once thought.

Guests

• Barry Kramer: MD, associate director for disease prevention at the National Institutes of Health.
• P. Kelly Marcom: MD, clinical director breast medical oncology at Duke University, where he is an assistant professor of oncology. And he is the director of the Hereditary Cancer Clinic.

Resources

• Barry Kramer, "Are We Overscreened?"
• About Kelly Marcom